期刊文献+

唑来膦酸合成方法的研究进展 被引量:3

Research Progress on the Synthetic Methods of Zoledronic Acid
下载PDF
导出
摘要 综述了唑来膦酸(1)合成方法的研究进展。重点介绍了以咪唑为原料合成1的工艺条件,讨论了不同工艺条件的优缺点。结果显示,通过优选相转移催化剂和溶剂能高收率地合成1。参考文献30篇。 Research progress on the synthetic methods of zoledronic acid(1) was reviewed with 30 references.The technology conditions of synthesis of 1 from imidazole were mainly introduced.Advantages and disadvantages of different technological conditions were discussed.The results showed that 1 in high yield was synthesized by selective preference of the phase transfer catalyst and solvent.
出处 《合成化学》 CAS CSCD 北大核心 2010年第6期660-663,共4页 Chinese Journal of Synthetic Chemistry
基金 国家自然科学基金资助项目(21073141)
关键词 唑来膦酸 咪唑 合成方法 催化剂 综述 zoledronic acid imidazole synthetical method catalyst review
  • 相关文献

参考文献30

  • 1张石革.双膦酸盐类药物的研究进展与合理应用[J].当代医学,2002,8(1):73-77. 被引量:2
  • 2Zardin P C.Anti-tumour activity of zoledronic acid[J].Cancer Treatment Reviews,2005,31:S1-S8.
  • 3Saag K,Lindsay R,Krlegman A.A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density[J].Bone,2007,40:1238-1243.
  • 4Inter M C,Holen Coleman R E.Exploring the anti-tumour activity of bisphosphonates in early breast cancer[J].Cancer Treatment Reviews,2008,34:453-475.
  • 5Green J R.Zoledronic acid:Pharmacologic profile of a potent bisphosphonate[J].Journal of Organometallic Chemistry,2005,690:2439-2448.
  • 6Rosen L S,Gordon D,Kaminski M,et al.Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma or breast carcinoma[J].Cancer,2003,98(8):1735-1744.
  • 7Perry C M,Figgitt D P.Zoledronic acid:A review of its use in patients with advanced cancer[J].Drugs,2004,64(11):1197-1211.
  • 8Jeanett E W,Karine B,Stephan R.Novel antiangiogenie effetes of the bisphophonate compound zoledronic acid[J].J Pharmaeol ExP Ther,2002,302:1055-1061.
  • 9胡文倩,张玉,张耕.唑来膦酸的合成新方法[P].CN 1 475 514A,2004.
  • 10蒋晔,张晓青,徐智儒.咪唑乙酸盐酸盐的制备[J].中国医药工业杂志,2004,35(4):204-205. 被引量:3

二级参考文献53

  • 1王磊,孙兴华.KF-Al_2O_3催化咪唑的N-烷基化反应[J].化学通报,1993(10):38-39. 被引量:9
  • 2王洪勇,罗世能,刘晓亚,谢敏浩,何拥军.唑来膦酸的合成方法改进[J].江南大学学报(自然科学版),2004,3(6):611-613. 被引量:5
  • 3蒋晔,张晓青,徐智儒.唑来膦酸的合成[J].华西药学杂志,2005,20(1):29-30. 被引量:8
  • 4高原,史达清,周龙虎,戴桂元.KF/Al_2O_3催化的羰基与活性亚甲基化合物的缩合反应[J].有机化学,1996,16(6):548-551. 被引量:50
  • 5KAMIJO T,YAMAMOTO R,HARADA H,et a1.An improved and convenient procedure for the synthesis of 1-substituted imidazoles[J].Chem.Pharm.Bull.,1983,31(5):1 213-1 221.
  • 6ZADERENKO P,GIL M S,BALLESTEROS P,et al.Synthesis and regioslective hydrolysis of 2-imidazol-1-ylsuccinic ester[J].J.Org.Chem.,1994,59(21):6 268-6 273.
  • 7BIRKOFER L,RICHTER P,RITTER A.Aktiviertmg N-haltiger heterocyclen durch silylierung[J].Chem.Ber.,1960,93(6):2 804-2 809.
  • 8DUPONT J,DE SOUZA R F,SUAREZ P A Z.Ionic liquids (molten salt)phase organometallic catalysis[J].Chem.Rev.,2002,102(10):3 667-3 691.
  • 9Perry C M, Figgitt D P. Zoledronic acid:a review of its use in patients with advanced cancer [J]. Drugs,2004,64(11):1197-1211.
  • 10Aronhime, Judith, Lifshitz L, et al. Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation [P]. US: 7,435,827.

共引文献85

同被引文献29

  • 1蒋晔,张晓青,徐智儒.唑来膦酸的临床研究进展[J].中国医院药学杂志,2004,24(9):561-563. 被引量:8
  • 2WIDLER L,JAEGGI K,GLAAT M. Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid(Zometa)[J].Journal of Medicinal Chemistry,2002,(17):3721-3738.doi:10.1021/jm020819i.
  • 3SAAG K,LINDSAY R,KRIEGMAN A. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density[J].Bone,2007,(05):1238-1243.
  • 4YAMADA J,TSUNO N H,KITAYAMA J J. Antiangiogenic property of zoledronic acid by inhibition of endothelial progenitor cell differentiation[J].Journal of Surgical Research,2009,(01):115-120.
  • 5GREEN J R. Zoledronic acid:pharmacologic profile of a potent bisphosphonate[J].Journal of Organometallic Chemistry,2005,(10):2439-2448.
  • 6ROSEN L S,GORDON D,KAMINSKI M. Longterm efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma or breast carcinoma[J].Cancer,2003,(08):1735-1744.
  • 7MUDDASANI P R,VATTIKUTI U R,NANNAPANENI V C. An improved process for the preparation of zoledro nicacid[P].WO,2005063717,2005.
  • 8SINGH S K,MANNE N,RAY P C. Synthesis of imidazol-l-yl-acetic acid hydrochloride:a key intermediate for zoledronic acid[J].Beilstein Journal of Organic Chemistry,2008,(42).
  • 9JAEGGI K A,WIDL ER L. Substituted alikanediposphonic acid and pharmaceutical use[P].US,4939130,1990.
  • 10JYOTY P,VINOD K T,SHYAM S V. Synthesis and antitubercular screening of imidazole derivatives[J].European Journal of Medicinal Chemistry,2009,(08):3350-3355.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部